Key facts
- FlyteHealth’s last known valuation is $90.0M (Nov 2025).
- It has raised $49.9M; the latest was Later Stage VC ($5.2M) in Nov 2025.
- Notable investors include Connecticut Innovations, The Venture Collective, 25madison, Hearst Ventures, Amplifyher Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for FlyteHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for FlyteHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About FlyteHealth
Developer of medical technology software and clinical services designed to transform the perception and treatment of obesity. The company's software helps to diagnose obesity-related diseases and provides an evaluation of each patient and customized recommendations for treatment and ongoing care, also integrates, tracks, and manages lab data and pharmacotherapy recommendations, enabling medical professionals to diagnose patients at high risk of developing metabolic complications due to their weight.
- Sector
- Healthcare
- HQ
- New Canaan, CT, United States
- Founded
- 2018
- Employees
- 93
- Website
- flytehealth.com/
- Ownership
- Privately Held (backing)
FlyteHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FlyteHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FlyteHealth in its N-PORT filings yet. We sweep new filings monthly.